Plain-Language Summary
Plain-language reading of the public trial registries.
In short
- Buserelin has a real but limited body of human research.
- 31 registered studies in total.
- None are currently enrolling — this research has already happened.
What kind of research
- 31 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
- About 14,723 people took part in those.
How far along it is
- 24 trials have reached phase 3 or 4 — the large, late-stage trials regulators rely on to approve a drug.
- 10 have published results in the medical literature that anyone can read.
- The research spans 14 countries.
A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.
Filter
Showing 31 of 31 trials for Buserelin.
UTN-01-2022
Friedrich-Schiller-Universitaet Jena
prostate cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve
Tanta University
Intracytoplasmic Sperm Injection · GnRH Agonist · Infertility · Ovarian Reserve
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
NRG Oncology
Prostate Adenocarcinoma
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
NRG Oncology
Prostate Adenocarcinoma · Stage III Prostate Cancer AJCC v8 · Stage IVA Prostate Cancer AJCC v8
Modified Downregulation for Women With Adenomyosis of the Uterus Prior to Frozen-thawed Embryo Transfer.
University College, London
Adenomyosis
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Dual Ovarian Stimulation (Duostim) and Shanghai Protocols in Poor Ovarian Responders
Royan Institute
Assisted Reproductive Techniques
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Dual Trigger" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome
Mount Sinai Hospital, Canada
Ovarian Hyperstimulation Syndrome · Infertility, Female
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation
Mount Sinai Hospital, Canada
Infertility
Efficacy of Ovarian Stimulation Based on FSHR Genotype Status
Medical University of Vienna
Sterility
The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients
Peter Humaidan
Infertility
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer
Institut Paoli-Calmettes
Non Castrate Metastatic Prostate Cancer
Molecular Evaluation of Endometrium After Endometrial Injury
Royan Institute
Endometrial Injury
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles
Andros Day Surgery Clinic
In Vitro Fertilization · Ovarian Stimulation
The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol
European Hospital
Embryo's Genetic and Chromosomal Quality
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Radiation Therapy Oncology Group
Prostate Cancer
Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist
Universitair Ziekenhuis Brussel
Reproductive Endocrinology · Fertility · Optimal Stimulation Protocol
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Radiation Therapy Oncology Group
Prostate Cancer
Mild Stimulation Protocol Versus Microdose Gonadotropin-releasing Hormone Agonist Flare up Protocol in Poor Responders
Yazd Medical University
Pregnancy
Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles
Regionshospitalet Viborg, Skive
OHSS (Ovarian Hyperstimulation)
Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification
Yazd Research & Clinical Center for Infertility
In Vitro Fertilization
Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer
NCIC Clinical Trials Group
Prostate Cancer
Antagonist/Letrozole in Poor Responders
Yazd Research & Clinical Center for Infertility
Ovarian Stimulation
Agonist Gonadotropin-Releasing Hormone (GnRH) Versus Antagonist GnRH
Yazd Research & Clinical Center for Infertility
Infertility
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
Radiation Therapy Oncology Group
Prostate Cancer
Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist
Yazd Research & Clinical Center for Infertility
Ovarian Stimulation
Duration of GnRH-analogue Downregulation and Pregnancy Rates
Aristotle University Of Thessaloniki
Infertility
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin
Tehran University of Medical Sciences
Infertility
Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer
NCIC Clinical Trials Group
Prostate Cancer
Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
NCIC Clinical Trials Group
Prostate Cancer
Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
NCIC Clinical Trials Group
Prostate Cancer
Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Neoplasm, Prostate
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Buserelin is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.